Tim Holland‐Letz

ORCID: 0000-0003-0348-8163
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Prostate Cancer Treatment and Research
  • Radiopharmaceutical Chemistry and Applications
  • Optimal Experimental Design Methods
  • Prostate Cancer Diagnosis and Treatment
  • Statistical Methods in Clinical Trials
  • Cutaneous Melanoma Detection and Management
  • AI in cancer detection
  • Melanoma and MAPK Pathways
  • Cancer Immunotherapy and Biomarkers
  • Radiomics and Machine Learning in Medical Imaging
  • Hematopoietic Stem Cell Transplantation
  • RNA Interference and Gene Delivery
  • Advanced Multi-Objective Optimization Algorithms
  • Computational Drug Discovery Methods
  • Colorectal Cancer Screening and Detection
  • MicroRNA in disease regulation
  • Immune Cell Function and Interaction
  • Immune cells in cancer
  • Neuroblastoma Research and Treatments
  • DNA Repair Mechanisms
  • Cancer Genomics and Diagnostics
  • Sepsis Diagnosis and Treatment
  • Glioma Diagnosis and Treatment
  • Medical Imaging Techniques and Applications
  • Cardiac Imaging and Diagnostics

German Cancer Research Center
2016-2025

Heidelberg University
2016-2025

DKFZ-ZMBH Alliance
2013-2022

Heidelberger Institut für Radioonkologie
2019

National Center for Tumor Diseases
2019

Medical University of Vienna
2016

Comprehensive Cancer Center Vienna
2016

University Hospital of Zurich
2016

University of Zurich
2016

National Institutes of Health
2016

Abstract Tractography based on non-invasive diffusion imaging is central to the study of human brain connectivity. To date, approach has not been systematically validated in ground truth studies. Based a simulated data set with tracts, we organized an open international tractography challenge, which resulted 96 distinct submissions from 20 research groups. Here, report encouraging finding that most state-of-the-art algorithms produce tractograms containing 90% bundles (to at least some...

10.1038/s41467-017-01285-x article EN cc-by Nature Communications 2017-11-01

Since the introduction of positron emission tomography (PET) imaging with 68Ga-PSMA-HBED-CC (=68Ga-DKFZ-PSMA-11), this method has been regarded as a significant step forward in diagnosis recurrent prostate cancer (PCa). However, published data exist for small patient cohorts only. The aim evaluation was to analyse diagnostic value 68Ga-PSMA-ligand PET/CT large cohort and influence several possibly interacting variables. We performed retrospective analysis 319 patients who underwent from 2011...

10.1007/s00259-014-2949-6 article EN cc-by European Journal of Nuclear Medicine and Molecular Imaging 2014-11-20

Positron emission tomography (PET) with choline tracers has found widespread use for the diagnosis of prostate cancer (PC). However, metabolism is not increased in a considerable number cases, whereas prostate-specific membrane antigen (PSMA) overexpressed most PCs. Therefore, (68)Ga-labelled PSMA ligand could be superior to by obtaining high contrast. The aim this study was compare such novel tracer standard choline-based PET/CT.Thirty-seven patients biochemical relapse PC [mean (PSA) 11.1...

10.1007/s00259-013-2525-5 article EN cc-by European Journal of Nuclear Medicine and Molecular Imaging 2013-09-26

Abstract Purpose Since the clinical introduction of 68 Ga-PSMA-11 PET/CT, this imaging method has rapidly spread and is now regarded as a significant step forward in diagnosis recurrent prostate cancer (PCa). The aim study was to analyse influence several variables with possible on PSMA ligand uptake large cohort. Methods We performed retrospective analysis 1007 consecutive patients who were scanned PET/CT (1 h after injection) from January 2014 2017 detect disease. Patients untreated...

10.1007/s00259-017-3711-7 article EN cc-by European Journal of Nuclear Medicine and Molecular Imaging 2017-05-11
Titus J. Brinker Achim Hekler Alexander Enk Joachim Klode Axel Hauschild and 95 more Carola Berking Bastian Schilling Sebastian Haferkamp Dirk Schadendorf Tim Holland‐Letz Jochen Utikal Christof von Kalle Wiebke Ludwig‐Peitsch Judith Sirokay Lucie Heinzerling Magarete Albrecht Katharina Baratella Lena Bischof Eleftheria Chorti Anna Dith Christina Drusio Nina Giese Emmanouil Gratsias Klaus Griewank Sandra Hallasch Zdenka Hanhart Saskia Herz Katja Hohaus Philipp Jansen Finja Jockenhöfer Theodora Kanaki Sarah Knispel Katja Leonhard Anna Martaki Liliana Matei Johanna Matull Alexandra Olischewski Maximilian Petri Jan‐Malte Placke Simon Raub Katrin Salva Swantje Schlott Elsa Sody Nadine Steingrube Ingo Stoffels Selma Ugurel Anne Zaremba Christoffer Gebhardt Nina Booken Maria Christolouka Kristina Buder‐Bakhaya Therezia Bokor‐Billmann Alexander Enk Patrick Gholam Holger Hänßle Martin Salzmann Sarah K. Schäfer Knut Schäkel Timo Schank Ann‐Sophie Bohne Sophia Deffaa Katharina Drerup Friederike Egberts Anna‐Sophie Erkens Benjamin Ewald Sandra Falkvoll Sascha Gerdes Viola Harde Axel Hauschild Marion Jost Katja Kosova Laetitia Messinger Malte Metzner Kirsten Morrison Rogina Motamedi Anja Pinczker Anne Rosenthal Natalie Scheller Thomas Schwarz Dora Stölzl Federieke Thielking Elena Tomaschewski Ulrike Wehkamp Michael Weichenthal Oliver Wiedow Claudia Bär Sophia Bender-Säbelkampf Marc Horbrügger Ante Karoglan Luise Kraas Jörg Faulhaber Cyrill Géraud Ze Guo Philipp Koch Miriam Linke Nolwenn Maurier Verena Müller Benjamin Thomas Jochen Utikal Ali Saeed M. Alamri

Recent studies have successfully demonstrated the use of deep-learning algorithms for dermatologist-level classification suspicious lesions by excessive proprietary image databases and limited numbers dermatologists. For first time, performance a algorithm trained open-source images exclusively is compared to large number dermatologists covering all levels within clinical hierarchy.We used methods from enhanced deep learning train convolutional neural network (CNN) with 12,378 dermoscopic...

10.1016/j.ejca.2019.04.001 article EN cc-by-nc-nd European Journal of Cancer 2019-04-10

PET imaging with the prostate-specific membrane antigen (PSMA)–targeted radioligand <sup>68</sup>Ga-PSMA-11 is regarded as a significant step forward in diagnosis of prostate cancer (PCa). More recently, PSMA ligand was developed that can be labeled <sup>68</sup>Ga, <sup>111</sup>In, <sup>177</sup>Lu, and <sup>90</sup>Y. This ligand, named PSMA-617, therefore enables both therapy PCa. The aims this evaluation were to clinically investigate distribution <sup>68</sup>Ga-PSMA-617 normal tissues...

10.2967/jnumed.115.161299 article EN Journal of Nuclear Medicine 2015-08-20

Immunotherapy with ipilimumab improves the survival of patients metastatic melanoma. Because only around 20% experience long-term benefit, reliable markers are needed to predict a clinical response. Therefore, we sought determine if some myeloid cells and related inflammatory mediators could serve as predictive factors for patients' response ipilimumab.We performed an analysis in peripheral blood 59 stage IV melanoma before treatment at different time points upon therapy using laboratory...

10.1158/1078-0432.ccr-15-0676 article EN Clinical Cancer Research 2015-08-20

BackgroundMelanoma is the most dangerous type of skin cancer but curable if detected early. Recent publications demonstrated that artificial intelligence capable in classifying images benign nevi and melanoma with dermatologist-level precision. However, a statistically significant improvement compared dermatologist classification has not been reported to date.MethodsFor this comparative study, 4204 biopsy-proven (1:1) were used for training convolutional neural network (CNN). New techniques...

10.1016/j.ejca.2019.05.023 article EN cc-by-nc-nd European Journal of Cancer 2019-08-08
Achim Hekler Jochen Utikal Alexander Enk Axel Hauschild Michael Weichenthal and 95 more Roman C. Maron Carola Berking Sebastian Haferkamp Joachim Klode Dirk Schadendorf Bastian Schilling Tim Holland‐Letz Benjamin Izar Christof von Kalle Stefan Fröhling Titus J. Brinker Laurenz Schmitt Wiebke K. Peitsch Friederike Hoffmann Jürgen C. Becker Christina Drusio Philipp Jansen Joachim Klode Georg Lodde Stefanie Sammet Dirk Schadendorf Wiebke Sondermann Selma Ugurel Jeannine Zader Alexander Enk Martin Salzmann Sarah K. Schäfer Knut Schäkel Julia K. Winkler Priscilla Wölbing Hiba Asper Ann‐Sophie Bohne Victoria Brown Bianca Burba Sophia Deffaa Cecilia Dietrich Matthias Dietrich Katharina Drerup Friederike Egberts Anna‐Sophie Erkens Salim Greven Viola Harde Marion Jost Merit Kaeding Katharina Kosova S. Lischner Maria Maagk Anna Laetitia Messinger Malte Metzner Rogina Motamedi Ann-Christine Rosenthal Ulrich Seidl Jana Stemmermann Kaspar Torz Juliana Giraldo Velez Jennifer Haiduk Mareike Alter Claudia Bär Paul Bergenthal Anne Gerlach Christian Holtorf Ante Karoglan Sophie Kindermann Luise Kraas Moritz Felcht Maria Rita Gaiser Claus‐Detlev Klemke Hjalmar Kurzen Thomas Leibing Verena Müller Raphael Reinhard Jochen Utikal Franziska Winter Carola Berking Laurie Eicher Daniela Hartmann Markus V. Heppt Katharina Kilian Sebastian Krammer Diana Lill Anne‐Charlotte Niesert Eva Oppel Elke Sattler Sonja Senner Jens Wallmichrath Hans Wolff Anja Gesierich Tina Giner Valerie Glutsch Andreas Kerstan Dagmar Presser Philipp Schrüfer Patrick Schummer Ina Stolze Judith Weber

BackgroundIn recent studies, convolutional neural networks (CNNs) outperformed dermatologists in distinguishing dermoscopic images of melanoma and nevi. In these artificial intelligence were considered as opponents. However, the combination classifiers frequently yields superior results, both machine learning among humans. this study, we investigated potential benefit combining human for skin cancer classification.MethodsUsing 11,444 images, which divided into five diagnostic categories,...

10.1016/j.ejca.2019.07.019 article EN cc-by-nc-nd European Journal of Cancer 2019-09-10

BackgroundThe diagnosis of most cancers is made by a board-certified pathologist based on tissue biopsy under the microscope. Recent research reveals high discordance between individual pathologists. For melanoma, literature reports 25–26% for classifying benign nevus versus malignant melanoma. Deep learning was successfully implemented to enhance precision lung and breast cancer diagnoses. The aim this study illustrate potential deep assist human assessment histopathologic melanoma...

10.1016/j.ejca.2019.04.021 article EN cc-by-nc-nd European Journal of Cancer 2019-05-23
Roman C. Maron Michael Weichenthal Jochen Utikal Achim Hekler Carola Berking and 95 more Axel Hauschild Alexander Enk Sebastian Haferkamp Joachim Klode Dirk Schadendorf Philipp Jansen Tim Holland‐Letz Bastian Schilling Christof von Kalle Stefan Fröhling Maria Rita Gaiser Daniela Hartmann Anja Gesierich Katharina C. Kähler Ulrike Wehkamp Ante Karoglan Claudia Bär Titus J. Brinker Laurenz Schmitt Wiebke K. Peitsch Friederike Hoffmann Jürgen C. Becker Christina Drusio Philipp Jansen Joachim Klode Georg Lodde Stefanie Sammet Dirk Schadendorf Wiebke Sondermann Selma Ugurel Jeannine Zader Alexander Enk Martin Salzmann Sarah K. Schäfer Knut Schäkel Julia K. Winkler Priscilla Wölbing Hiba Asper Ann‐Sophie Bohne Victoria Brown Bianca Burba Sophia Deffaa Cecilia Dietrich Matthias Dietrich Katharina Drerup Friederike Egberts Anna‐Sophie Erkens Salim Greven Viola Harde Marion Jost Merit Kaeding Katharina Kosova S. Lischner Maria Maagk Anna Laetitia Messinger Malte Metzner Rogina Motamedi Ann-Christine Rosenthal Ulrich Seidl Jana Stemmermann Kaspar Torz Juliana Giraldo Velez Jennifer Haiduk Mareike Alter Claudia Bär Paul Bergenthal Anne Gerlach Christian Holtorf Ante Karoglan Sophie Kindermann Luise Kraas Moritz Felcht Maria Rita Gaiser Claus‐Detlev Klemke Hjalmar Kurzen Thomas Leibing Verena Müller Raphael Reinhard Jochen Utikal Franziska Winter Carola Berking Laurie Eicher Daniela Hartmann Markus V. Heppt Katharina Kilian Sebastian Krammer Diana Lill Anne‐Charlotte Niesert Eva Oppel Elke Sattler Sonja Senner Jens Wallmichrath Hans Wolff Tina Giner Valerie Glutsch

BackgroundRecently, convolutional neural networks (CNNs) systematically outperformed dermatologists in distinguishing dermoscopic melanoma and nevi images. However, such a binary classification does not reflect the clinical reality of skin cancer screenings which multiple diagnoses need to be taken into account.MethodsUsing 11,444 images, covered dermatologic comprising majority commonly pigmented lesions faced screenings, CNN was trained through novel deep learning techniques. A test set...

10.1016/j.ejca.2019.06.013 article EN cc-by-nc-nd European Journal of Cancer 2019-08-14

Accurate melanoma diagnosis is crucial for patient outcomes and reliability of AI diagnostic tools. We assess interrater variability among eight expert pathologists reviewing histopathological images clinical metadata 792 melanoma-suspicious lesions prospectively collected at German hospitals. Moreover, we provide access to the largest panel-validated dataset featuring dermoscopic with metadata. Complete agreement achieved in 53.5% cases (424/792), a majority vote ( ≥ five pathologists)...

10.1038/s41467-025-56160-x article EN cc-by Nature Communications 2025-01-17

BACKGROUND: The GERMS Group initiated a prospective multicenter study to assess prevalence and nature of bacterial contamination pooled buffy‐coat platelet concentrates (PPCs) apheresis (APCs) by routine screening with culture system. STUDY DESIGN AND METHODS: In nine centers overall, 52,243 (PLT) (15,198 APCs, 37,045 PPCs) were analyzed aerobic anaerobic cultures (BacT/ALERT, bioMérieux). RESULTS: 135 PLT (PCs; 0.26%), bacteria could be identified in the first (0.4% for APCs vs. 0.2% PPCs;...

10.1111/j.1537-2995.2007.01166.x article EN Transfusion 2007-02-16

Since the introduction of PSMA PET/CT with 68Ga-PSMA-11, this modality for imaging prostate cancer (PC) has spread worldwide. Preclinical studies have demonstrated that short-term androgen deprivation therapy (ADT) can significantly increase expression on PC cells. Additionally, retrospective clinical data in large patient cohorts suggest a positive association between ongoing ADT and pathological scan. The present evaluation was conducted to further analyse influence long-term findings. A...

10.1007/s00259-018-4079-z article EN cc-by European Journal of Nuclear Medicine and Molecular Imaging 2018-07-06

Background: Artificial intelligence has shown promise in numerous experimental studies, particularly skin cancer diagnostics. Translation of these findings into the clinic is logical next step. This translation can only be successful if patients’ concerns and questions are addressed suitably. We therefore conducted a survey to evaluate view artificial melanoma diagnostics Germany. Participants Methods: A web-based questionnaire was designed using LimeSurvey, sent by e-mail university...

10.3389/fmed.2020.00233 article EN cc-by Frontiers in Medicine 2020-06-02
Coming Soon ...